01002nas a2200133   4500008004100000245003000041210002900071260001800100300001200118490000700130520064900137100001800786856006400804       2023                        eng d00aDrug Review: Terlipressin0 aDrug Review Terlipressin  cFebruary 2024  a138-1390 v123 a<p class="rtejustify">Registrations: It had been registered in the following countries: United Kingdom (UK), United States of America (USA), Canada, and Saudi Arabia (SA). Trade name (USA.); TERLIVAZ ® Registration number (SA); 11-367-07. Insurance Drug Formulary (SA); Covered. General Information: Registered Company: Mallinckrodt hospital products inc. Regulatory Status: RX. Mechanism of Action: Prodrug The active form is lysine vasopressin, the non-selective agonist of both V1 (smooth muscles of the arterial vasculature in the splanchnic region) and V2 receptors (collecting ducts of renal tubules). <strong>Read more...</strong></p>
1 aAlsaab, Juman  uhttps://www.ijphs.org/article/2023/12/3/105530ijpcs20231217